Cardiovascular physician information from @MethodistHosp heart specialists at the internationally-renowned DeBakey Heart & Vascular Center.
Houston, TX
Joined November 2018
- Tweets1.8K
- Following261
- Followers4.1K
- Likes2.5K
Houston Methodist CV retweeted
At Grand Rounds today, we had the pleasure of hosting Dr. Phelan from Atrium Health, who presented on sports cardiology. Join us in person or online every Thursday from 8-9 a.m. CST.
Watch it here: bit.ly/4yrPSU3
#HoustonMethodist #GrandRounds #DeBakeyCVEducation
Houston Methodist CV retweeted
@DermotPhelanMD giving a great grand rounds today at @DeBakeyCVedu @HMethodistCV on The Athlete’s Heart 🫀
Such a changing field, for the better- partnering with the patients to make decisions where evidence is limited, but growing
Houston Methodist CV retweeted
A lovely evening at our home with the Faculty of MMI.26 conference, celebrating our 15th yr & special Friendship. Look forward to MMI.27 on October 9-10. Post it on your calendar 😊@HMethodistCV @ACCinTouch @ASE360 @escardio @SCMRorg @MyASNC @worldheartfed @Heart_SCCT
Houston Methodist CV retweeted
Please join us for a very exciting Grand Rounds this Thursday with Dr. @DermotPhelanMD
@WilliamZoghbi @khurramn1 @DeBakeyCVedu @AtriumHealth
Join us October 15 at 8am CST for grand rounds featuring Dermot Phelan, MD, PhD, presenting “New Era in the Game: Pioneering Advances in Sports Cardiology.”
Watch LIVE: bit.ly/GR101526
#HoustonMethodist #DeBakeyCVEdu #GrandRounds
Join us at the 2026 Digital Health Institute Symposium where leaders in medicine, engineering, public health & policy will explore what it takes for digital health technologies to improve outcomes, lower cost, build trust & reach communities.
Register: hmrdhi.org/events/2026-dhi-f…
A study, enabled by the @RiceUniversity-Houston Methodist Digital Health Institute, has identified four distinct patient profiles in aortic regurgitation, including a high-risk group of women whose disease often appears milder by traditional measures. spr.ly/6016BH8A5q
Dr. @rnacorejpc, chair of the department of cardiovascular sciences, presents groundbreaking data on how telomerase therapy can reverse cellular aging processes linked to cardiovascular disease.
Learn more on YouTube: spr.ly/6015BH8xy3
A study, enabled by the @RiceUniversity-Houston Methodist Digital Health Institute, has identified four distinct patient profiles in aortic regurgitation, including a high-risk group of women whose disease often appears milder by traditional measures. spr.ly/6016BH8A5q
Could geography influence epilepsy risk? Dr. @weichuandong explores America's “Epilepsy Belt” across the South and what environmental and healthcare factors may mean for patient care on @NPR's The @AcademicMinute.
Tune in: spr.ly/6010BG40vn
What are free radicals, and how are they affecting our cells? Dr. @rnacorejpc explores how telomerase may protect skin cells from radiation damage on @NPR's The @AcademicMinute.
Tune in: spr.ly/6015BGFHZP
Houston Methodist CV retweeted
Phew, what a whirlwind at #ESVS2026! @HMethodistCV represented! Love the fast-track format with hundreds of amazing abstracts. Honored to judge and be invited faculty this year! Shoutout to Enikő and Peter representing our lab! More pics to come. @AlanLumsdenMD
By bringing vascular surgery and engineering together, a team of researchers, led by Dr. Maham Rahimi, is developing EndoEx—a novel approach designed to make complex endograft explantation safer and more controlled.
Learn more in @VascularNews: spr.ly/6014BGFKp0
Houston Methodist CV retweeted
How does where we live shape our risk of type 2 diabetes?
On today’s The Academic Minute, I share our research on climate vulnerability and diabetes risk @HMethodistCV @C3PH_HM. 🎙️
Listen here: academicminute.org/p/jad-ard…
@Sadeer_AlKindi @khurramn1 @AcademicMinute @MethodistHosp
Houston Methodist CV retweeted
In only 1wk! interact with world-renown MMI experts: AI in CV Imaging/valvular heart/HCM/Sarcoid/amyloid... Recording available for 2 mo. Priced for global audience:25-50$! tinyurl.com/57k3hmu4
@HMethodistCV @HMHCardioFellow @JACCJournals @SachinGoelMD @escardio @NadeenFaza
Houston Methodist CV retweeted
T-2 weeks!! Meet & interact with world leaders in MMI: innovations/structural heart/IHD/CM/cases. Recordings available for 2 mo. Priced for a global audience: 25-50$!
@ACCinTouch @ASE360 @SAC_54 @thecsanz @BritishCardioSo @TheSaudiHeart @IAEecho @IaciIndia tinyurl.com/57k3hmu4
Houston Methodist CV retweeted
Thank you @SVM_tweets for inviting me to share our work on predicting progression from PAD to CLTI. I’ve loved the passionate multidisciplinary conversations at my first SVM meeting and enjoyed it so much that I applied to join the Society! #VSS2026
Houston Methodist CV retweeted
At the XXXI World Congress of Echocardiography and Allied Techniques in Abu Dhabi, addressing valvular heart disease updates. Thx Drs Ghalal AlKilani & Firas Al Badarin for the invitation. Quite an impressive program & setting ! @ASE360 @ACCinTouch @HMethodistCV @falbadarin
Dr. @khurramn1, our chief of Cardiovascular Disease Prevention and Wellness, discusses how coronary artery calcium (CAC) scoring has emerged as the most precise tool for cardiovascular risk stratification.
Learn more on YouTube: spr.ly/6013BGUbAD
Cardiovascular imaging plays a vital role in the management of our cardiovascular patients. Join us for the 14th Annual Multimodality Cardiovascular Imaging for the Clinician, presented by @DeBakeyCVedu.
To learn more & register: spr.ly/6011BEAvDf
Dr. @MdSchaal interviews Dr. @trisharoymd in the newest installment of Women in Surgery. Dr. Roy discusses her path to becoming a vascular surgeon-scientist and materials engineer, her bench-to-bedside translational research program and more.
Watch here: spr.ly/6015BGb9dV
Houston Methodist CV retweeted
Today I had the honour of being with the @NIH with the #NHlBI & #NIDDK with this amazing working group trying to determine what should be the next clinical trial in #Type1diabetes led by Drs. Paul Ridker & Bob Eckel
Patients with T1D deserve evidence based care, not assumptions from T2D trials #CVPrev
🚨Finally a new drug approval for CKD in T1D! 1st drug in 30 years
🫘 #Finerenone reduces urinary albumin-to-creatinine ratio (UACR) in adults with CKD & T1D, which slows CKD progression
Congratulations to @Bayer for studying this important group #FINEONE
Now let’s do more outcome studies of T1D with other drugs that are being used off label. They deserve evidence based care
breakthrought1d.org/news-and…
